MYGN - MYRIAD GENETICS INC

QQQ $ 431.37 $ -1.78 (-0.41 %)

DIA $ 383.00 $ -0.19 (-0.05 %)

SPY $ 509.05 $ -1.20 (-0.24 %)

TLT $ 88.80 $ 0.16 (0.18 %)

GLD $ 216.34 $ 0.13 (0.06 %)

Previous Close

$ 18.18

Open

$ 18.50

Bid

$ 19.19 x 100

Ask

$ 19.25 x 100

Day's Range

$ 18.45 - $ 19.10

52 Week Range

$ 13.82 - $ 24.21

Volume

518,695

Average Volume

Market Cap

1.51B

Beta (5Y Monthly)

$ 1.38

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-04-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-02-2022	09-30-2022	10-Q
7	08-05-2022	06-30-2022	10-Q
8	05-06-2022	03-31-2022	10-Q
9	02-25-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-04-2021	06-30-2021	10-Q
12	05-05-2021	03-31-2021	10-Q
13	11-09-2020	09-30-2020	10-Q
14	08-13-2020	06-30-2020	10-K
15	05-06-2020	03-31-2020	10-Q
16	02-07-2020	12-31-2019	10-Q
17	11-06-2019	09-30-2019	10-Q
18	08-13-2019	06-30-2019	10-K
19	05-08-2019	03-31-2019	10-Q
20	02-06-2019	12-31-2018	10-Q
21	11-07-2018	09-30-2018	10-Q
22	08-24-2018	06-30-2018	10-K
23	05-09-2018	03-31-2018	10-Q
24	02-07-2018	12-31-2017	10-Q
25	11-08-2017	09-30-2017	10-Q
26	08-09-2017	06-30-2017	10-K
27	05-03-2017	03-31-2017	10-Q
28	02-08-2017	12-31-2016	10-Q
29	11-02-2016	09-30-2016	10-Q
30	08-10-2016	06-30-2016	10-K
31	05-04-2016	03-31-2016	10-Q
32	02-03-2016	12-31-2015	10-Q
33	11-04-2015	09-30-2015	10-Q
34	08-12-2015	06-30-2015	10-K
35	05-06-2015	03-31-2015	10-Q
36	02-04-2015	12-31-2014	10-Q
37	11-05-2014	09-30-2014	10-Q
38	08-13-2014	06-30-2014	10-K
39	05-07-2014	03-31-2014	10-Q
40	02-05-2014	12-31-2013	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

New Myriad Genetics Published Study Demons...
04/16/2024 13:18:59

Myriad Genetics Research Shows Reduction I...
04/09/2024 12:05:05

Reported Earlier, Myriad Genetics Granted ...
03/22/2024 07:14:37

Myriad Genetics Says US Patent And Tradema...
03/20/2024 20:08:13

U.S. Patent No. 11,932,907, titled Fetal Sex Determination Using Capillary Blood From Upper Arm, provides protection for Myriad...

Myriad Genetics Sees 2024 Adj. EPS $0.00-$...
02/27/2024 22:08:46

Myriad Genetics: Q4 Earnings Insights
02/27/2024 21:50:09

Myriad Genetics Q4 2023 Adj EPS $0.04 Beat...
02/27/2024 21:47:53

Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01...

Myriad Genetics And National Cancer Center...
02/27/2024 14:16:51

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced a research collaborati...

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

Myriad Genetics Earnings Preview
02/26/2024 16:01:44

Goldman Sachs Maintains Buy on Myriad Gene...
01/30/2024 13:59:39

Goldman Sachs analyst Matthew Sykes maintains Myriad Genetics (NASDAQ:MYGN) with a Buy and raises the price target from $28 ...

Peeling Back The Layers: Exploring Myriad ...
01/29/2024 16:01:13

Goldman Sachs Maintains Buy on Myriad Gene...
01/29/2024 15:33:41

Goldman Sachs analyst Matthew Sykes maintains Myriad Genetics (NASDAQ:MYGN) with a Buy and raises the price target from $28 ...

Myriad Genetics Acquires Precise Tumor, Pr...
01/19/2024 06:28:21

"With this acquisition, we're deepening our commitment to our oncology business while also generating a more effective ...

genetic-testing-pioneer-myriad-genetics-evolution-draws-analyst-attention-amid-new-products-anticipation

Genetic Testing Pioneer Myriad Genetics' E...
12/21/2023 18:05:53

Piper Sandler initiated coverage on Myriad Genetics Inc (NASDAQ: MYGN), noting that many investors know the company as one of t...

Myriad Genetics Appoints Of Scott Leffler ...
12/21/2023 13:33:43

Evaluating Myriad Genetics: Insights From ...
12/21/2023 12:00:14

Piper Sandler Initiates Coverage On Myriad...
12/21/2023 10:36:19

Piper Sandler analyst John Peterson initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Neutral rating and announces ...

Myriad Genetics Establishes Comprehensive ...
12/20/2023 13:03:27

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the launch of the Myri...

Wells Fargo Initiates Coverage On Myriad G...
12/19/2023 16:08:50

Wells Fargo analyst Timothy Daley initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Equal-Weight rating and announc...